Literature DB >> 28384911

Occurrence of Anxiety and Depression among Stable COPD Patients and its Impact on Functional Capability.

Debabani Biswas1, Subhasis Mukherjee1, Rajarshi Chakroborty2, Somsubhra Chatterjee3, Subrata Rath4, Runa Das5, Shabana Begum6.   

Abstract

INTRODUCTION: Anxiety and depression are important but often under-diagnosed co-morbid conditions in patients with Chronic Obstructive Pulmonary Disease (COPD) which may affect the functional capacity of the patients. AIM: To find out the proportion of depression and anxiety among stable COPD patients using a validated questionnaire suitable for use in clinic and the factors affecting their reduced functional capability as assessed by six-minute walk test.
MATERIALS AND METHODS: This was a descriptive cross-sectional study. Seventy five patients diagnosed with stable COPD in outpatient Department of Pulmonary Medicine in a tertiary care hospital, satisfying all inclusion criteria, were included in the study. They were examined clinically, categorized as per Global Initiative for Chronic Obstructive Lung Disease (GOLD) severity assessment guideline and interviewed by designated interviewer using validated questionnaire for depression (Hamilton depression rating scale, HAM-D) and anxiety (State Trait Anxiety Inventory, STAI). The functional exercise capacity of the patient was assessed by six-minute walk test. Statistical analysis was performed using Minitab software (version16.1).
RESULTS: Among 75 stable COPD patients (68 male, 7 female), majority (32 out of 75) had both depression and anxiety, while only anxiety or depression was present in 9 each. The patients with depression had no significant difference in six-minute walk distance, change in heart rate and respiratory rate (p = 0.4186, 0.219 and 0.41 respectively) as compared to those without depression, but were found to be more dyspnoeic at the end of the test (p= 0.003). There was also no significant difference in walk distance in patients with high STAI score as compared to those with low STAI score (p= 0.276).
CONCLUSION: Both anxiety and depression were present in majority of the stable COPD patients. The presence of these co-morbid conditions had no significant effect on the functional status of the patients in the form of reduced six-minute walk distance, though they were more symptomatic than those without these co-morbidities.

Entities:  

Keywords:  Clinical COPD Questionnaire; Hamilton depression rating scale; Six-minute walk test; State trait anxiety inventory

Year:  2017        PMID: 28384911      PMCID: PMC5376823          DOI: 10.7860/JCDR/2017/24203.9393

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

1.  Functional and psychological variables both affect daily physical activity in COPD: a structural equations model.

Authors:  Wytske A Altenburg; Linda Bossenbroek; Mathieu H G de Greef; Huib A M Kerstjens; Nick H T ten Hacken; Johan B Wempe
Journal:  Respir Med       Date:  2013-06-28       Impact factor: 3.415

Review 2.  Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Peter F Collins; Marinos Elia; Rebecca J Stratton
Journal:  Respirology       Date:  2013-05       Impact factor: 6.424

3.  Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study.

Authors:  Nicholas D Giardino; Jeffrey L Curtis; Adin-Cristian Andrei; Vincent S Fan; Joshua O Benditt; Mark Lyubkin; Keith Naunheim; Gerard Criner; Barry Make; Robert A Wise; Susan K Murray; Alfred P Fishman; Frank C Sciurba; Israel Liberzon; Fernando J Martinez
Journal:  Respir Res       Date:  2010-03-09

4.  State and trait anxiety in women affected by allergic and vasomotor rhinitis.

Authors:  G Addolorato; C Ancona; E Capristo; R Graziosetto; L Di Rienzo; M Maurizi; G Gasbarrini
Journal:  J Psychosom Res       Date:  1999-03       Impact factor: 3.006

5.  Psychiatric morbidity in chronic respiratory disorders in an Indian service using GMHAT/PC.

Authors:  Bharat Bhushan Sharma; Sheetu Singh; Vimal Kumar Sharma; Manoj Choudhary; Virendra Singh; Steven Lane; Peter Lepping; Murali Krishna; John Copeland
Journal:  Gen Hosp Psychiatry       Date:  2012-10-31       Impact factor: 3.238

Review 6.  Anxiety and depression in end-stage COPD.

Authors:  K Hill; R Geist; R S Goldstein; Y Lacasse
Journal:  Eur Respir J       Date:  2008-03       Impact factor: 16.671

7.  Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients.

Authors:  Jennifer A Cleland; Amanda J Lee; Susan Hall
Journal:  Fam Pract       Date:  2007-05-15       Impact factor: 2.267

Review 8.  Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review.

Authors:  Rie Lambaek Mikkelsen; Thomas Middelboe; Charlotta Pisinger; Kurt Bjerregaard Stage
Journal:  Nord J Psychiatry       Date:  2004       Impact factor: 2.202

9.  Prevalence of psychiatric comorbidities in chronic obstructive pulmonary disease patients.

Authors:  Shyam Chand Chaudhary; Satyan Nanda; Adarsh Tripathi; Kamal Kumar Sawlani; Kamlesh Kumar Gupta; D Himanshu; Ajay Kumar Verma
Journal:  Lung India       Date:  2016 Mar-Apr

10.  Presence of depression and its risk factors in patients with chronic obstructive pulmonary disease.

Authors:  Harish Negi; Malay Sarkar; Amit D Raval; Krishna Pandey; Pradeep Das
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

View more
  3 in total

1.  Effects of the health belief model following acute exacerbation of chronic obstructive pulmonary disease in a hospital in China.

Authors:  Mei Ji; Ai-Hong Wang; Jun Ye; Ya-Hui Shen; Chun-Mei Chen; Chen Yu; Li-Fang Li
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

2.  Sleepiness, fatigue, anxiety and depression in Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea - Overlap - Syndrome, before and after continuous positive airways pressure therapy.

Authors:  Nicholas-Tiberio Economou; Ioannis Ilias; Lemonia Velentza; Yiannis Papachatzakis; Paul Zarogoulidis; Anastasios Kallianos; Georgia Trakada
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

3.  Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation.

Authors:  Yvonne M J Goërtz; Martijn A Spruit; Alex J Van 't Hul; Jeannette B Peters; Maarten Van Herck; Nienke Nakken; Remco S Djamin; Chris Burtin; Melissa S Y Thong; Arnold Coors; Yvonne Meertens-Kerris; Emiel F M Wouters; Judith B Prins; Frits M E Franssen; Jean W M Muris; Lowie E G W Vanfleteren; Mirjam A G Sprangers; Daisy J A Janssen; Jan H Vercoulen
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.